Lead Sponsor

Daniel Maroti

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

•The participant certifies that they have undergone a medical evaluation for their physical symptoms.
•The participant rates either moderate distress from physical symptoms on the PHQ-15 form (over 10 points) or significant distress from a single physical symptom (at least 2 points for that symptom).
•The participant expresses interest in exploring whether emotional factors, such as stress, may contribute to their symptom profile.
•Any prescribed medications must have been stable for at least 1 month.
•Participants must meet the criteria for non-response/treatment resistance, i.e., no reliable change in PHQ-15.

•Participants suffer from ongoing substance abuse (alcohol or drugs) or are assessed to have severe mental health issues (psychotic disorders, moderate to high suicide risk, antisocial personality disorder, etc.).
•Participants are currently prescribed medications that are clearly addictive and sedative in nature (e.g., benzodiazepines).
•Participants are involved in other psychological treatments focused on physical symptoms. However, other psychological treatments are allowed as long as the supportive therapy does not occur more than once a month.
•Participants do not have sufficient proficiency in the Swedish language.
•Somatic symptoms is judged to be need further medically evaluation or treatment.

Related studies

NCT06163014 · Persistent Physical Symptoms

NCT05946512 · Post COVID-19 Condition, Somatic Symptom Disorder

NCT06909669 · Depression - Major Depressive Disorder, Generalized Anxiety Disorder, and more

NCT07115472 · Superior Mesenteric Artery Syndrome, Somatic Symptom Disorder (DSM-5)

NCT06506136 · Refractory Constipation, Somatic Symptom Disorder (DSM-5), and more

ISTDP for Patients with Treatment Resistance PPS